期刊文献+

JS-K对Hela细胞、A375细胞和HL-60细胞增殖的影响

Effect of JS-K on the cell proliferation in human HL-60,A375 and Hela cells
下载PDF
导出
摘要 目的探讨JS-K对人白血病HL-60细胞、黑色素瘤A375细胞以及宫颈癌Hela细胞增殖的影响。方法采用MTT法检测细胞生长情况,观察JS-K在0.3~10.0μmol/L浓度范围内对Hela细胞、A375细胞和HL-60细胞生长的影响,计算其抑制率;在倒置显微镜下观察细胞的形态学变化。结果MTT法检测发现,JS-K在0.3~10.0μmol/L处理HL-60细胞24-96h,反映活细胞数量的OD值呈时间依赖性和剂量依赖性的降低;JS-K对HL-60细胞的生长的抑制率则明显增高;显微镜下也可见,3.0和10.0μmol/L的JS-K作用96h后,HL-60细胞的数量明显减少,细胞碎片增加;96hJS-K对于HL-60的IC50为0.58±0.01μmol/L。与空白组比较,0.3~10.0μmol/LJS-K作用Hela细胞、A375细胞24-96h,反映活细胞数量的OD值和镜下所见细胞数量和形态未见明显改变。结论JS-K对Hela细胞、A375细胞的增殖则无明显作用,而对HL-60细胞增殖具有明显的抑制作用,其作用机制值得进一步深入研究。 Objective To explore the effects of JS-K on the cells proliferation in human cervical carcinoma Hela cells, human melanoma A375 cells and human myeloid leukemia HL-60 cells. Methods The cell viability was detected by MTT method. The effect of JS-K (0.3-10.0 μmol/L) was observed on the growth of Hela ceils, A375 cells and HL-60 cells from 24 to 96 hours.Then the inhibition percentages of the growth of HL-60 cells proliferation were calculated. The morphologic changes were observed through inverted microscope. Results JS-K (0.3-10.0μmol/L) obviously decreased OD values of HL-60 cells by MTT method in a time-dependent and dose-dependent manner; And the inhibitory percentages of HL-60 cells growth were increased, The 50% inhibition concentration was 0.58±0.01μmol/L at 96 hour. JS-K did not affect on the OD value, and has no change of number and morphous in Hela cells and A375 cell. Condusions JS-K has inhibitory growth in HL-60 cells in vitro, but not in Hela cells and A375 cells. The anticancer mechanism is further worth of studying.
出处 《遵义医学院学报》 2008年第6期562-564,共3页 Journal of Zunyi Medical University
关键词 JS—K HL-60细胞 宫颈癌细胞 黑色素瘤细胞 增殖 JS-K Hela cell A375 cell HL-60 cell proliferation
  • 相关文献

参考文献6

  • 1Denninger J W. Marietta MA. Guanylate cyelase and the NO/c GMP signaling pathway[J]. Biochim Biophys Acta, 1999, 141(3): 334-350.
  • 2Ushmorov A, Ratter F, Lehmanni V. Nitric oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and release [J]. Blood,1999, 93(7): 2342- 2352.
  • 3Shami PJ, Sauls DL, Weinberg JB. Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide[J]. Leukemia,1998, 12:1461-1466.
  • 4Keefer LK, Nims RW, Davies KM,Wink DA. NONOate as nitric oxide donors: convenient nitric oxide dosage forms[J]. Methods Enzymol, 1996, 268:281-293.
  • 5Saavedra JE, Shami P J, Wang LY, Davies KM, Keefer LK. Esterase -sensitive nitric oxide donors of the diazeniumdiolate family. Invitro antileukemic activity [J].J Med Chem, 2000, 43: 261-269.
  • 6Shami PJ, Saavedra J-E, Bonifant CL, Antitumor activity of JS-K [02- (2, 4-dinitrophenyl) 1 -[(4-ethoxycarbonyl) piperazin-l-yl] diazen-l-ium-1, 2- diolate] and related 02-aryl diazeniumdiolates in vitro and in vivo[J]. J Med Chem, 2006, 49 (14): 4356--4366.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部